Document ID: chunk:federal_register_of_legislation:F2024C01228:front:0:p7
Version: federal_register_of_legislation:F2024C01228
Segment Type: other
Provision Reference: 
Character Range: 15415–18546

therapy; or
                  (G) is pregnant.

     (8)  For item 207A, 207B and 207F of Schedule 1, a designated vaccine mentioned in that item may be provided to any of the following:
         (a)  a person who is at least 65 years old or
          (b) an Aboriginal or Torres Strait Islander person who is at least 6 months old; or
         (c) a child who is at least 6 months old but less than 5 years old; or
         (d) a person who is at least 6 months old and who:

            (i) has cardiac disease including cyanotic congenital heart disease, coronary artery disease and congestive heart failure; or
            (ii) has a chronic respiratory condition including suppurative lung disease, bronchiectasis, cystic fibrosis, chronic obstructive pulmonary disease, chronic emphysema and severe asthma; or
            (iii) has another chronic illness requiring regular medical follow‑up or hospitalisation in the preceding year, including diabetes mellitus, chronic metabolic diseases, chronic renal failure, haemoglobinopathies and impaired immunity (including drug‑induced immune impairment); or
            (iv) has a chronic neurological condition, including multiple sclerosis, spinal cord injuries, seizure disorders or other neuromuscular disorders; or

            (v) has impaired immunity, including HIV infection; or

         (e) a person who is at least 6 months old but is less than 11 years old and is receiving long‑term aspirin therapy; or

         (f) a woman who is pregnant.

     (8A) For item 207C of Schedule 1, a designated vaccine mentioned in that item may be provided to:
         (a)  a person who is at least 65 years; or
          (b) an Aboriginal or Torres Strait Islander person who is aged at least 5 years; or
         (c)  a person who is at least 5 years who:

            (i) has cardiac disease including cyanotic congenital heart disease, coronary artery disease and congestive heart failure; or
            (ii) has a chronic respiratory condition including suppurative lung disease, bronchiectasis, cystic fibrosis, chronic obstructive pulmonary disease, chronic emphysema and severe asthma; or
            (iii) has another chronic illness requiring regular medical follow‑up or hospitalisation in the preceding year, including diabetes mellitus, chronic metabolic diseases, chronic renal failure, haemoglobinopathies and impaired immunity (including drug‑induced immune impairment); or
            (iv) has a chronic neurological condition, including multiple sclerosis, spinal cord injuries, seizure disorders or other neuromuscular disorders; or

            (v) has impaired immunity, including HIV infection; or
         (d)  a woman who is pregnant.

 (9) For item 208A of Schedule 1, a designated vaccine mentioned in that item may be provided to:
 (a) an Aboriginal and/or Torres Strait Islander person who is:
 (i) aged at least 6 months but less than 3 years; or
 (b) a person who is at least 6 months but less than 3 years
 (i) who:
 (A) has cardiac disease including cyanotic congenital heart disease, coronary artery disease and congestive heart failure; or
 (B)